Skip to Main Content
Yale Head and Neck SPORE
YSM Home

INFORMATION FOR

Symposia

The US government is, far and away, the most generous national funder of cancer research in the world providing more than 50 percent of the billions invested each year. In turn, the National Cancer Institute (NCI), an independent research institute within the US government, is the primary driver of US cancer research and training. Three decades ago NCI established the Specialized Programs of Research Excellence (SPORE), to foster collaborative, interdisciplinary translational cancer research among multiple institutions. The award of SPORE grant money signals support for a specific program, in this case the Yale Head & Neck Cancer SPORE which includes cancer research experts from Fox Chase Cancer Center/Temple University, and University of North Carolina (UNC).

Each year, dozens of those experts meet for a symposium to share their work and ideas. Folllowing are reports on recent meetings. Access by clicking on the titles in each calendar item.


Past Symposia

Jun 202527Friday
  • Yale Only
    Robert L. Ferris, MD, PhD

    Yale Head and Neck SPORE CEP & DRP Symposium 2025

    Register to attend: https://yalesurvey.ca1.qualtrics.com/jfe/form/SV_0iJiKKBQ4wi7QEu

    For Zoom link, please contact Katie.Behr@yale.edu

    Presentations by pilot project awardees:

    Oneida Arosarena, MD (Fox Chase Cancer Center): A Small Molecule Leucine Carboxyl Methyltransferase-1 Inhibitor Radiosensitizes Head and Neck Squamous Carcinoma Cells

    Yash Chhbra, PhD (Fox Chase Cancer Center): Deciphering Age and Sex Disparity in the HPV-negative Tongue Squamous Cell Carcinoma Microenvironment

    Michael Chiorazzi, MD, PhD (Yale Cancer Center): Remodeling of the HPV+ HNSCC Tumor and Lymph Node Microenvironment by Immune Checkpoint Inhibitors and Demethylating Therapy

    Lilian Kabeche, PhD (Yale Cancer Center): Leveraging ATR Regulation of Centromere Identity in HNSCC

    Samuel Katz, MD, PhD (Yale Cancer Center): Engineering the T Cell Cytoskeleton for Improved Solid Tumor CAR-T Cytotoxicity

    Travis Schrank, MD, PhD (University of North Carolina): Pharmacological NF-kB activation as a strategy for radio-sensitization of high-risk HPV+ HNSCC

    Thuy Tran, MD, PhD (Yale Cancer Center): Targeting the MIF/DDT-CD74 Signaling Axis to Enhance Immunotherapy Responses to SCCs

    West Campus
    Add event to Calendar
Download The Calendar